✦ LIBER ✦

A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Scribed by Natalie Gould; Michael W. Sill; Robert S. Mannel; Premal H. Thaker; Paul A. DiSilvestro; Steven E. Waggoner; S. Diane Yamada; Deborah K. Armstrong; Paula M. Fracasso; Joan L. Walker

Book ID: 118506853
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 162 KB
Volume: 127
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2012.08.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study with an expanded cohort

A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Natalie Gould; Michael W. Sill; Robert S. Mannel; P.H. Thaker; Paul DiSilvestro; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase I study with an expanded cohort

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Mark A. Morgan; Michael W. Sill; Keiichi Fujiwara; Benjamin Greer; Stephen C. Ru 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Phase I feasibility study of intraperito

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study

✍ Don S. Dizon; Michael W. Sill; Natalie Gould; Stephen C. Rubin; S. Diane Yamada; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase I feasibility trial of carboplatin

Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study

✍ Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

A phase I trial of dose-dense (biweekly)

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: A feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: A Gynecologic Oncology Group study

✍ Amy D. Tiersten; Michael W. Sill; Danielle Knight; Franco Muggia; Agustin A. Gar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Randomized phase III trial of tamoxifen

Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study

✍ Jean A. Hurteau; Mark F. Brady; Kathleen M. Darcy; William P. McGuire; Pamela Ed 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 490 KB